Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens-Ulrich Rahfeld

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Peptides|January 16, 2007
Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4Nadine Frerker, Leona Wagner, Raik Wolf, et al.
Neurobiology of Aging|October 11, 2015
An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 miceJeffrey L Frost, Bin Liu, Jens-Ulrich Rahfeld, et al.
Angewandte Chemie (International Ed. in English)|March 13, 2016
Enhanced Fibril Fragmentation of N-Terminally Truncated and Pyroglutamyl-Modified Aβ PeptidesMelanie Wulff, Monika Baumann, Anka Thümmler, et al.
Biochemistry|June 16, 2011
Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active centerDavid Ruiz-Carrillo, Birgit Koch, Christoph Parthier, et al.
Journal of Neurochemistry|March 27, 2016
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragmentLeona Wagner, Maria Björkqvist, Sofia Hult Lundh, et al.
The Journal of Biological Chemistry|January 6, 2021
Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitisNadine Taudte, Miriam Linnert, Jens-Ulrich Rahfeld, et al.
The Journal of Biological Chemistry|April 10, 2021
Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitisNadine Taudte, Miriam Linnert, Jens-Ulrich Rahfeld, et al.
The Protein Journal|September 6, 2015
The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradationNalise Low Ah Kee, Jason Krause, Gregory L Blatch, et al.
International Journal of Cancer|November 12, 2021
CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cellsYi Liu, Sanmei Wang, Maria-Luisa Schubert, et al.
Alzheimer'S Research & Therapy|November 15, 2020
Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathologyKathrin Gnoth, Anke Piechotta, Martin Kleinschmidt, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Peptides|January 16, 2007
Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4Nadine Frerker, Leona Wagner, Raik Wolf, et al.
Neurobiology of Aging|October 11, 2015
An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 miceJeffrey L Frost, Bin Liu, Jens-Ulrich Rahfeld, et al.
Angewandte Chemie (International Ed. in English)|March 13, 2016
Enhanced Fibril Fragmentation of N-Terminally Truncated and Pyroglutamyl-Modified Aβ PeptidesMelanie Wulff, Monika Baumann, Anka Thümmler, et al.
Biochemistry|June 16, 2011
Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active centerDavid Ruiz-Carrillo, Birgit Koch, Christoph Parthier, et al.
Journal of Neurochemistry|March 27, 2016
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragmentLeona Wagner, Maria Björkqvist, Sofia Hult Lundh, et al.
The Journal of Biological Chemistry|January 6, 2021
Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitisNadine Taudte, Miriam Linnert, Jens-Ulrich Rahfeld, et al.
The Journal of Biological Chemistry|April 10, 2021
Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitisNadine Taudte, Miriam Linnert, Jens-Ulrich Rahfeld, et al.
The Protein Journal|September 6, 2015
The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradationNalise Low Ah Kee, Jason Krause, Gregory L Blatch, et al.
International Journal of Cancer|November 12, 2021
CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cellsYi Liu, Sanmei Wang, Maria-Luisa Schubert, et al.
Alzheimer'S Research & Therapy|November 15, 2020
Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathologyKathrin Gnoth, Anke Piechotta, Martin Kleinschmidt, et al.
Pageof 5